Navigation Links
New Guidelines Recommend Opioids for Seniors' Pain
Date:5/7/2009

NSAID use for persistent aches needs to be curbed, Geriatrics Society says

THURSDAY, May 7 (HealthDay News) -- The use of non-steroidal anti-inflammatory drugs (NSAIDs) or cox-2 inhibitors to treat persistent pain in seniors should be drastically reduced, according to new pain management guidelines released this week by the American Geriatrics Society (AGS).

The original guidelines recommended the use of over-the-counter or prescription NSAIDs and cox-2 inhibitors such as aspirin or ibuprofen before seniors were prescribed an opioid drug to treat persistent pain.

But this is a risky strategy in older patients, because the cardiovascular, gastrointestinal and other risks posed by the drugs often outweigh the benefits, the authors of the new guidelines said. They said NSAIDs and cox-2 inhibitors should be used rarely, and with extreme caution, in highly selected patients.

All older patients with moderate to severe pain or diminished quality of life due to pain should be considered for opioid therapy, which may be safer for many patients than long-term use of NSAIDs, according to the updated guidelines.

"Because the most common strategy for management of persistent pain among older persons is the use of pharmacologic agents, and because this is also the area of greatest risk, we chose to focus on pharmacotherapy in this update," Dr. Bruce Ferrell, guidelines panel chair, said in an AGS news release.

"Since the two previous AGS publications, new drugs have been introduced and management strategies have been more fully evaluated, so we felt it was important to focus on pharmacotherapy in this update," Ferrell explained.

The new guidelines will appear in the August issue of the Journal of the American Geriatrics Society.

Persistent pain is common among older people. If ongoing pain is ignored or incorrectly treated, patients can suffer problems such as falls, sleep disruptions, depression and anxiety, according to background information in the release.

"Persistent pain isn't a 'normal' part of aging and should not be ignored. As seniors become susceptible to more complex health ailments, the need for a clear and precise pain management plan is key," Dr. Cheryl Phillips, AGS president, said in the news release.

More information

The National Pain Foundation has more about seniors and pain.



-- Robert Preidt



SOURCE: American Geriatrics Society, news release, May 5, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Board of Trade Issues Business Preparation Guidelines for H1N1 Virus Outbreak
2. American Slide Chart/Perrygraf "SlideGuides" and "SpinGuides" Help Drug Companies Satisfy New PhRMA Guidelines
3. EMPOWERx E-Prescribing Solution Provides Latest Treatment Guidelines for 2008-2009 H1N1 Influenza Virus
4. Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines
5. T-System Releases Free Clinician Swine Flu Templates, Incorporating Updated CDC Interim Guidelines for Diagnosis and Treatment
6. Guidelines for medical home demonstrations released by major physician groups
7. Guidelines: Pregnancy Safe with Epilepsy, but Valproate Should be Avoided
8. An Innovative New Book Helps Consumers Find Out if Their Doctors are Following Official Treatment Guidelines
9. PDAs, more education help doctors follow cholesterol treatment guidelines
10. Cardinal Rigali Criticizes Draft NIH Guidelines for Destructive Stem Cell Research
11. NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Guidelines Recommend Opioids for Seniors' Pain
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 ... ... A new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... dogs. The study was published in the prestigious Journal of Veterinary Science & ...
(Date:12/7/2016)... ... ... Delete® - Tattoo Removal and Laser Salon Offers Delightful Holiday Deals On ... 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 , Delete® - ... on Botox® and Juvederm® just in time for the holiday party season. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX editors ... said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes 30 ... drop zones. Editors can select from a variety of flip book animations. In Addition, ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “The Road ... is an everyday trial, not a one hour a week showing of hands. “The ... businessman. , Tom begins, “Perhaps you are familiar with the brass ring that you ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... individuals impacted by cerebral cavernous angiomas, was awarded a grant from the Julian ... engagement program. New Mexico has more people with cavernous angioma than anywhere in ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- According to a new market research report "Clinical Decision ... Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity (Active, Passive), Application - ... reach USD 1,519.2 Million by 2021 from USD 856.3 Million in 2016, ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... Dec. 7, 2016  Organovo Holdings, Inc. (NASDAQ: ... company focused on delivering scientific and medical breakthroughs ... Chairman and Chief Executive Officer Keith Murphy ... Wednesday, December 14, 2016 at 1:00 p.m. Eastern ... not yet familiar with the Company, an informational ...
(Date:12/7/2016)... According to the latest market ... Study on Multiplex Detection Immunoassay: North America to Dominate ... detection immunoassay market is expected to witness a CAGR of ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
Breaking Medicine Technology: